Skip to main content
. 2018 Mar 8;15(5):475–483. doi: 10.7150/ijms.23044

Table 2.

Clinical characteristics of SS patients and controls.

Clinical Characteristics SS Controls Test p Value
Thyroid disease 22 (30,6%) 10 (13,9%) χ2= 5,786 0.016
Arthromyalgia / polyarticular arthritis 14 (19,4%) 3 (4,2%) Χ2 = 8,070 0.004
Esophageal disease 10 (13,9%) 1 (1,4%) Χ2 = 7,973 0.005
Gastritis 14 (19,4%) 0 Χ2 = 15,507 < 0.001
Interstitial lung disease 6 (8,3%) 0 Fisher exact test 0.014
Kidney disease 7 (9,7%) 1 (1,4%) Fisher exact test 0.031
Liver disease 7 (9,7%) 0 Fisher exact test 0.006
Neuropathy 9 (12,5%) 1 (1,4%) Χ2 = 6,878 0.009
Vasculitis 6 (8,3%) 0 Fisher exact test 0.014
Raynaud disease 25 (34,7%) 0 Χ2 = 30,252 < 0.001
Lymphoproliferative disorders 2 (2,8%) 0 Fisher exact test 0.248
Blood disorders 9 (12,5%) 1 (1,4%) Χ2 = 6,878 0.009
Osteoporosis 22 (30,6%) 1 (1,4%) Χ2 = 22,818 < 0.001
Hypovitaminosis 27 (37,5%) 1 (1,4%) Χ2 = 29,970 < 0.001
Hypertension 24 (33,3%) 19 (26,4%) Χ2 = 0,829 0.362
Diabetes mellitus 5 (6,9%) 4 (5,6%) Fisher exact test 00.05
Cardiopathy 14 (19,4%) 5 (6,9%) Χ2 4,912 0.027
Dyslipidemia 10 (13,9%) 3 (4,2%) Χ2 4,143 0.042